NephroGenex
Raleigh, US · Delaware corporation · 3 employees on LinkedIn · 1 known investors
Founders & leadership
Board
RS
Robert SeltzerBoard director
ES
RM
Richard MarkhamBoard director
MT
Marco TagliettiBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 1 round · 2015
▶$5.5MraisedNov 2015 · 14 investors · PharmaceuticalsRule 506(b)
▶$5.5MraisedNov 2015 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert SeltzerDirector
- Eugen SteinerDirector
- Jaikrishna PatelExecutive Officer
- Marco TagliettiDirector
- Pierre LegaultExecutive Officer, Director
- James MitchumDirector
- John HamillExecutive Officer
- Richard MarkhamDirector
- Offering amount
- $28.5M
- Amount sold
- $5.5M
- Sales commissions
- $357.5K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are NephroGenex's investors?
- NephroGenex's investors include HealthCap.
- How much funding has NephroGenex raised?
- NephroGenex has disclosed $5.5M raised across 1 round.
- Where is NephroGenex headquartered?
- NephroGenex is headquartered in Raleigh, US.